A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism

Journal of Nutrition and Metabolism

Volumn 2012, Issue , 2012, Pages

  McDonald, Ian ^a   Connolly, Maureen ^a   Tobin, Anne Marie ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873850444     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2012/965385     Document Type: Review

References (26)

1. Naldi L., Epidemiology of psoriasis. Current Drug Targets: Inflammation and Allergy 2004 3 2 121 128 2-s2.0-3042593698 10.2174/1568010043343958 (Pubitemid 38832741)
2. Gelfand J. M., Stern R. S., Nijsten T., Feldman S. R., Thomas J., Kist J., Rolstad T., Margolis D. J., The prevalence of psoriasis in African Americans: results from a population-based study. Journal of the American Academy of Dermatology 2005 52 1 23 26 2-s2.0-11144327646 10.1016/j.jaad.2004. 07.045 (Pubitemid 40038931)
3. Russo P. A., IIchef R., Cooper A. J., Psychiatric morbidity in psoriasis: a review. Australasian Journal of Dermatology 2004 45 3 155 159
4. Kimball A. B., Jacobson C., Weiss S., Vreeland M. G., Wu Y., The psychosocial burden of psoriasis. American Journal of Clinical Dermatology 2005 6 6 383 392 2-s2.0-31144475609 10.2165/00128071-200506060-00005 (Pubitemid 43128290)
5. Gelfand J. M., Neimann A. L., Shin D. B., Wang X., Margolis D. J., Troxel A. B., Risk of myocardial infarction in patients with psoriasis. Journal of the American Medical Association 2006 296 14 1735 1741 2-s2.0-33749613119 10.1001/jama.296.14.1735 (Pubitemid 44547793)
6. Henseler T., Christophers E., Disease concomitance in psoriasis. Journal of the American Academy of Dermatology 1995 32 6 982 986 2-s2.0-0029053726 10.1016/0190-9622(95)91336-X
7. Friedewald V. E., Cather J. C., Gelfand J. M., Gordon K. B., Gibbons G. H., Grundy S. M., Jarratt M. T., Krueger J. G., Ridker P. M., Stone N., Roberts W. C., AJC Editor's concensus: psoriasis and coronary artery disease. American Journal of Cardiology 2008 102 12 1631 1643 2-s2.0-58149477214 10.1016/j.amjcard.2008.10.004
8. Malerba M., Gisondi P., Radaeli A., Girolomoni G., Psoriasis and risk of myocardial infarction. Journal of the American Medical Association 2007 297 4 361 362 2-s2.0-33846536792
9. Tobin A. M., Hughes R., Hand E. B., Leong T., Graham I. M., Kirby B., Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study. Clinical and Experimental Dermatology 2011 36 1 19 23 2-s2.0-78650111602 10.1111/j.1365-2230.2010.03877.x
10. McDonald C. J., Calabresi P., Thromboembolic disorders associated with psoriasis. Archives of Dermatology 1973 107 6 918
11. Naldi L., Mercuri S. R., Epidemiology of comorbidities in psoriasis. Dermatologic Therapy 2010 23 2 114 118 2-s2.0-77950116876 10.1111/j.1529-8019. 2010.01304.x
12. Neimann A. L., Shin D. B., Wang X., Margolis D. J., Troxel A. B., Gelfand J. M., Prevalence of cardiovascular risk factors inpatientswith psoriasis. Journal of the American Academy of Dermatology 2006 55 5 829 835 2-s2.0-33749662118 10.1016/j.jaad.2006.08.040 (Pubitemid 44556851)
13. Prodanovich S., Kirsner R. S., Kravetz J. D., Ma F., Martinez L., Federman D. G., Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Archives of Dermatology 2009 145 6 700 703 2-s2.0-67449110958 10.1001/archdermatol.2009.94
14. Kremers H. M., McEvoy M. T., Dann F. J., Gabriel S. E., Heart disease in psoriasis. Journal of the American Academy of Dermatology 2007 57 2 347 354 2-s2.0-34447287339 10.1016/j.jaad.2007.02.007 (Pubitemid 47048862)
15. Malerba M., Gisondi P., Radaeli A., Sala R., Calzavara Pinton P. G., Girolomoni G., Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. British Journal of Dermatology 2006 155 6 1165 1169 2-s2.0-33750925900 10.1111/j.1365-2133.2006.07503.x (Pubitemid 44729990)
16. Morgan S. L., Baggott J. E., Lee J. Y., Alarcón G. S., Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention. Journal of Rheumatology 1998 25 3 441 446 2-s2.0-0031936472 (Pubitemid 28109342)
17. Refsum H., Helland S., Ueland P. M., Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clinical Pharmacology and Therapeutics 1989 46 5 510 520 2-s2.0-0024351118 (Pubitemid 20009867)
18. Hild D. H., Folate losses from the skin in exfoliative dermatitis. Archives of Internal Medicine 1969 123 1 51 57 2-s2.0-0014438686
19. Duell P. B., Malinow M. R., Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Current Opinion in Lipidology 1997 8 1 28 34 2-s2.0-0030888183 (Pubitemid 27148505)
20. Graham L. M., Daly L. E., Refsum H. M., Robinson K., Brattström L. E., Ueland P. M., Palma-Reis R. J., Boers G. H. J., Sheahan R. G., Lsraelsson B., Uiterwaal C. S., Meleady R., McMaster D., Verhoef P., Witteman J., Rubba P., Bellet H., Wautrecht J. C., De Valk H. W., Sales Lúis A. C., Parrot-Roulaud F. M., Tan K. S., Higgins I., Garcon D., Medrano M. J., Candito M., Evans A. E., Andria G., Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. Journal of the American Medical Association 1997 277 22 1775 1781 2-s2.0-1842331509 (Pubitemid 27247163)
21. Wotherspoon F., Laight D. W., Browne D. L., Turner C., Meeking D. R., Allard S. E., Munday L. J., Shaw K. M., Cummings M. H., Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabetic Medicine 2006 23 12 1350 1356 2-s2.0-33751246736 10.1111/j.1464-5491.2006.01980.x (Pubitemid 44787800)
22. Gisondi P., Fantuzzi F., Malerba M., Girolomoni G., Folic acid in general medicine and dermatology. Journal of Dermatological Treatment 2007 18 3 138 146 2-s2.0-34249798190 10.1080/09546630701247930 (Pubitemid 46854829)
23. Whittle S. L., Hughes R. A., Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology 2004 43 3 267 271 2-s2.0-1542359519 10.1093/rheumatology/keh088 (Pubitemid 38313172)
24. Prodanovich S., Ma F., Taylor J. R., Pezon C., Fasihi T., Kirsner S., Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. Journal of the American Academy of Dermatology 2005 52 2 262 267 10.1016/j.jaad.2004.06.017
25. Armitage J. M., Bowman L., Clarke R. J., Wallendszus K., Bulbulia R., Rahimi K., Haynes R., Parish S., Sleight P., Peto R., Collins R., Effects of homocysteine-lowering with folic acid plus vitamin B 12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. Journal of the American Medical Association 2010 303 24 2486 2494 2-s2.0-77953867844 10.1001/jama.2010.840
26. Boehncke W. H., Boehncke S., Tobin A. M., Kirby B., The "psoriatic march": a concept of how severe psoriasis may drive cardiovascular comorbidity. Experimental Dermatology 2011 20 4 303 307 2-s2.0-79952729906 10.1111/j.1600-0625.2011.01261.x